Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CO3N
|
||||
Former ID |
DIB018021
|
||||
Drug Name |
esuberaprost
|
||||
Synonyms |
APS-314D free acid; BPS-314d
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Gout [ICD9: 274.00274.1274.8274.9; ICD10:M10] | Phase 3 | [533330] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H30O5
|
||||
InChI |
InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+/t15-,17-,19+,20+,21-,23-/m0/s1
|
||||
InChIKey |
CTPOHARTNNSRSR-NOQAJONNSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Prostacyclin receptor | Target Info | Agonist | [533330] | |
Pathway Interaction Database | Thromboxane A2 receptor signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.